Form 4: Credo CFO Daniel Fleming Executes Planned Share Sale
Statement of Changes in Beneficial Ownership
Credo Technology Group Holding Ltd CFO Daniel Fleming sold 7,580 ordinary shares via a pre-arranged 10b5-1 trading plan.
Summary
- CFO Daniel W. Fleming sold a total of 7,580 ordinary shares of Credo Technology Group Holding Ltd on April 14, 2026.
- The sales were executed in two tranches: 6,669 shares at a weighted average price of $152.5086 and 911 shares at a weighted average price of $153.5362.
- Following these transactions, the reporting person retains beneficial ownership of 433,678 ordinary shares.
- The transactions were conducted under a Rule 10b5-1 trading plan adopted on January 12, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed under a pre-planned 10b5-1 arrangement, which is standard practice for executive financial management.
Positives
- The sale was conducted under a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.
Negatives
- The transaction represents a reduction in the direct equity stake held by the Chief Financial Officer.
Risks
- Insider selling can sometimes be perceived by the market as a signal that the stock price has reached a near-term peak.
Future Outlook
No forward-looking guidance or operational outlook was provided in this filing.
Management Comments
- The reporting person has committed to providing full information regarding the number of shares and prices at each trade upon request to the SEC staff, the issuer, or a security holder.
Industry Context
StockSavvy.ai notes that routine insider selling via 10b5-1 plans is common practice for executives in the semiconductor and technology sectors and generally does not reflect a change in corporate strategy or outlook.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate officers to manage personal liquidity while maintaining regulatory compliance.
Stakeholder Impact
- Minimal impact expected as the sale was pre-planned and represents a small portion of the CFO's total holdings.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2026-01-12 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-04-14 | Date of the reported share sale transactions. |
| 2026-04-16 | Date the Form 4 was signed and filed. |
Keywords
Credo Technology, CRDO, Insider Trading, Form 4, CFO, Equity Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.